GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Haohai Biological Technology Co Ltd (HKSE:06826) » Definitions » 5-Year Yield-on-Cost %

Shanghai Haohai Biological Technology Co (HKSE:06826) 5-Year Yield-on-Cost % : 0.95 (As of May. 15, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Shanghai Haohai Biological Technology Co 5-Year Yield-on-Cost %?

Shanghai Haohai Biological Technology Co's yield on cost for the quarter that ended in Mar. 2024 was 0.95.


The historical rank and industry rank for Shanghai Haohai Biological Technology Co's 5-Year Yield-on-Cost % or its related term are showing as below:

HKSE:06826' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.91   Med: 1.74   Max: 5.73
Current: 0.95


During the past 10 years, Shanghai Haohai Biological Technology Co's highest Yield on Cost was 5.73. The lowest was 0.91. And the median was 1.74.


HKSE:06826's 5-Year Yield-on-Cost % is ranked worse than
66.45% of 152 companies
in the Biotechnology industry
Industry Median: 1.765 vs HKSE:06826: 0.95

Competitive Comparison of Shanghai Haohai Biological Technology Co's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, Shanghai Haohai Biological Technology Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Haohai Biological Technology Co's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shanghai Haohai Biological Technology Co's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Shanghai Haohai Biological Technology Co's 5-Year Yield-on-Cost % falls into.



Shanghai Haohai Biological Technology Co 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Shanghai Haohai Biological Technology Co is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Shanghai Haohai Biological Technology Co  (HKSE:06826) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Shanghai Haohai Biological Technology Co 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Shanghai Haohai Biological Technology Co's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Haohai Biological Technology Co (HKSE:06826) Business Description

Traded in Other Exchanges
Address
No. 1386 Hongqiao Road, 23rd Floor, WenGuang Plaza, Changning District, Shanghai, CHN
Shanghai Haohai Biological Technology Co Ltd is engaged in the manufacturing and sale of biologicals, medical hyaluronate, and ophthalmology products. It is also engaged in the research and development of biological engineering, pharmaceutical and ophthalmology products, and the provision of related services. Its products are categorized into four types comprising ophthalmology, medical aesthetics, orthopedics, and anti-adhesion. Geographically, it has operations in Mainland China which is the key revenue driver, the United States, the United Kingdom, and other countries.

Shanghai Haohai Biological Technology Co (HKSE:06826) Headlines

No Headlines